يعرض 1 - 10 نتائج من 21 نتيجة بحث عن '"Hirsch, Hans H."', وقت الاستعلام: 0.68s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    المساهمون: Swiss Transplant Cohort Study (STCS)

    المصدر: Walti, Laura N.; Mugglin, Catrina; Sidler, Daniel; Mombelli, Matteo; Manuel, Oriol; Hirsch, Hans H.; Khanna, Nina; Mueller, Nicolas; Berger, Christoph; Boggian, Katia; Garzoni, Christian; Neofytos, Dionysios; van Delden, Christian; Hirzel, Cédric; Transplant Cohort Study Stcs, Swiss (2021). Association of Antiviral Prophylaxis and Rituximab Use with Post-transplant Lymphoproliferative Disorders (PTLD): A Nationwide Cohort Study. American journal of transplantation, 21(7), pp. 2532-2542. Wiley-Blackwell 10.1111/ajt.16423 <http://dx.doi.org/10.1111/ajt.16423Test>
    American journal of transplantation, vol. 21, no. 7, pp. 2532-2542
    American Journal of Transplantation

    مصطلحات موضوعية: Epstein-Barr Virus Infections, Herpesvirus 4, Human, medicine.medical_specialty, infectious disease, Lymphoproliferative disorders, immunosuppressant –fusion proteins and monoclonal antibodies: B cell specific, 610 Medicine & health, 030230 surgery, clinical research/practice, Antiviral Agents, Gastroenterology, Virus, infectious, hematology/oncology, immunosuppressant -fusion proteins and monoclonal antibodies: B cell specific, infection and infectious agents - viral, infection and infectious agents - viral: Epstein-Barr Virus (EBV), posttransplant lymphoproliferative disorder (PTLD) [Antiviral Agents/therapeutic use, Cohort Studies, Epstein-Barr Virus Infections/drug therapy, Humans, Lymphoproliferative Disorders/drug therapy, Lymphoproliferative Disorders/etiology, Lymphoproliferative Disorders/prevention & control, Rituximab/therapeutic use, complication], 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, medicine, Immunology and Allergy, Pharmacology (medical), In patient, posttransplant lymphoproliferative disorder (PTLD), Transplantation, infection and infectious agents – viral: Epstein‐Barr Virus (EBV), business.industry, Incidence (epidemiology), infection and infectious agents – viral, Clinical Science, medicine.disease, complication: infectious, Lymphoproliferative Disorders, 3. Good health, surgical procedures, operative, 030220 oncology & carcinogenesis, Cohort, Original Article, Rituximab, ORIGINAL ARTICLES, Complication, business, Cohort study, medicine.drug

    وصف الملف: application/pdf

  7. 7
  8. 8
  9. 9

    المساهمون: University of Zurich, Abela, Irene A

    المصدر: Clinical Infectious Diseases, Vol. 70, No 2 (2020) pp. 297-303
    Abela, Irene A; Scherrer, Alexandra U; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Perreau, Matthieu; Hirsch, Hans H; Furrer, Hansjakob; Calmy, Alexandra; Schmid, Patrick; Cavassini, Matthias; Bernasconi, Enos; Günthard, Huldrych F (2020). Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients. Clinical infectious diseases, 70(2), pp. 297-303. Oxford University Press 10.1093/cid/ciz178 <http://dx.doi.org/10.1093/cid/ciz178Test>

    وصف الملف: ciz178.pdf - application/pdf; application/pdf

  10. 10